Session 229

Structure and Innovation

Track I

Date: Sunday, October 7, 2012

 

Time: 15:15 – 16:30

Paper

Room: Terrace 1


Session Chair:

  • PuayKhoon Toh, University of Texas at Austin

Title: Hybrid Organizations and Pharmaceutical Innovations: Evidence from Brazil

Authors

  • Sandro Cabral, Insper Institute of Education and Research
  • Peter Klein, Baylor University
  • Sergio Lazzarini, Insper
  • Anita McGahan, University of Toronto

Abstract: We provide a theoretical framework for evaluating the relative efficiency of alternative organizational modes designed to foster entrepreneurship in social goods subject to externalities. We distinguish two possible roles of public and private actors: entrepreneurs (“agents”) and sponsors (“principals”); and derive a set of hypotheses about the interactions among funding sources, executor type, and other project characteristics and the effectiveness of innovation in the public interest. We then examine the nature and performance of hybrid organizational forms in addressing issues with substantial social externalities in the context of Brazil’s Fundaçion Osvaldo Cruz (Fiocruz). The results suggest powerful mechanisms of selection, with sponsorship and execution of projects aligned ex ante in anticipation of ex post incentive mechanisms.

Title: Structural Recombination and Innovation

Authors

  • Samina Karim, Northeastern University
  • Aseem Kaul, University of Minnesota

Abstract: This study examines how structural recombination of business units within firms affects firm innovation. We argue that structural change is a disruptive process harmful to innovation, but that the magnitude of this effect will depend upon the firm’s pre-divestment knowledge. Where the firm has weak technological capabilities or is diversified into unrelated technological areas, structural recombination will harm innovation. In contrast, where firms have strong and coherent technological capabilities, structural recombination may benefit innovation, unlocking the potential for knowledge recombination within the firm. Results from a panel of U.S. medical sector firms show support for these arguments. The study thus provides insight into the contingent nature of structural recombination, while highlighting the role of structural change in enabling recombinant innovation within the firm.

Title: The Impact of Governance Uncertainty on Innovation Outcomes

Authors

  • Bettina Bastian, American University of Beirut
  • Marcel Bogers, University of Copenhagen

Abstract: We address the link between governance uncertainty and innovation output. Our research focuses on the context of the upstream oil industry, where companies source natural resources from particular geographical areas. For these companies, governance uncertainty may constitute a serious threat to the business of natural resource exploitation. Companies respond to governance uncertainties that affect short-term assets (notably, production assets) with long-term solutions (diversification into green technologies), and to uncertainties that affect long-term assets (notably, newly explored resource deposits) with short-term solutions (investments into technical fields within their current core business). Our research is supported with an analysis of 16 years of data from diverse technology and operations areas of 13 global upstream oil and gas companies.

Title: Trapped By Your Knowledge Competencies? Impact of Alliance Portfolio Unique Patents On Firm Innovation Quality

Authors

  • Manish Srivastava, Michigan Technological University
  • Devi Gnyawali, Virginia Tech

Abstract: Do a focal firm’s alliance partners’ unique technologies impact the firm’s innovation quality? And what type of firms would be better prepared to leverage those unique technologies? These questions are critical because unique technologies could be beneficial for generating high quality innovations. Given the high risk associated with experimenting with such technologies internally, alliances could be helpful device. However, identifying unique technologies of alliance partners could be challenging, and leveraging these technologies effectively could be even more challenging to firms with strong internal competencies. We find that unique patent of alliance partners of firms contributes to greater overall quality of their innovations. However, firms that have strong internal knowledge base or have high internal knowledge search propensities, struggle in leveraging those unique patents.

All Sessions in Track I...

Sun: 08:00 – 09:15
Session 274: Knowledge Foundations: A Conversation with Robert Grant about the Knowledge Based View
Sun: 09:30 – 10:45
Session 273: Big Data, Knowledge and Innovation
Sun: 11:15 – 12:30
Session 275: The Changing Nature of Innovation in Emerging Economies
Sun: 15:15 – 16:30
Session 225: Intellectual Property Rights
Session 229: Structure and Innovation
Mon: 08:00 – 09:15
Session 223: Individuals, Teams and Innovation
Session 242: R&D
Mon: 09:30 – 10:45
Session 140: Knowledge Management & Knowledge Structures: Who knows?
Session 226: Technology
Session 235: Learning
Mon: 13:30 – 14:45
Session 222: Integrating Knowledge about Knowledge Integration
Session 227: Knowledge Transfer and Replication
Mon: 16:30 – 17:45
Session 224: Absorptive Capacity
Session 236: Innovation and Performance
Tue: 08:00 – 09:15
Session 230: Ties, Networks, and Innovation
Session 237: Open Innovation
Tue: 11:00 – 12:15
Session 228: Exploration
Session 231: Alliance and Transfer
Tue: 14:15 – 15:30
Session 234: Incumbent Response to Foreign Entry and to Disruptive Innovation
Session 240: Capabilities
Tue: 15:45 – 17:00
Session 233: Structure and Transfer
Session 243: Entrepreneurs, Ventures, and Innovation
Tue: 17:30 – 18:45
Session 232: Innovation and Transfer
Session 239: Ambidexterity / Exploration and Exploitation
Session 244: Knowledge Management


Strategic Management Society

Prague